As a small community hospital, Pennsylvania’s Doylestown Health had to rely on external services for next-generation sequencing. Here, Allison Eck explains how she was able to bring NGS testing in-house and the benefits it has brought to patients and researchers.
Doylestown Health has been on a mission since its inception over a century ago to serve the community and provide great care for every patient, every time. And we’ve accomplished that, having grown into a 245-bed hospital and a clinical laboratory processing more than one million tests annually.
But despite our growth in breadth of capabilities, we faced a crucial limitation: our pathology laboratory lacked the capacity to perform next-generation sequencing (NGS) in-house, which forced us to rely on outside reference laboratories for molecular testing. This often meant waiting up to three weeks for test results that could advance vital research. Plus, the cost of outsourcing these tests was putting a strain on our already stretched resources. As a small community hospital, we had to find a way to bring NGS in-house, but with our limited space and small team, it needed to be efficient and adaptable to our current laboratory setup.
The right NGS solution
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.